Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 8, 2008, Pages 794-799

  Sakaguchi, Tomoko ^a   Shimizu, Wataru ^b   Itoh, Hideki ^a   Noda, Takashi ^b   Miyamoto, Yoshihiro ^b   Nagaoka, Iori ^a   Oka, Yuko ^a   Ashihara, Takashi ^a   Ito, Makoto ^a   Tsuji, Keiko ^a   Ohno, Seiko ^c   Makiyama, Takeru ^c   Kamakura, Shiro ^b   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age; Bradycardia; Drugs; Genetic test; Hypokalemia; Long QT syndrome; Triggers

Indexed keywords

ADULT; AGE; AROUSAL; ARTICLE; ATRIOVENTRICULAR BLOCK; EMOTIONAL STRESS; EXERCISE; FEMALE; GENOTYPE; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKALEMIA; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NOISE; PRIORITY JOURNAL; REST; SCHOOL CHILD; SLEEP; SYNCOPE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; JAPAN; LONG QT SYNDROME; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 47749122982     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01138.x     Document Type: Article

References (27)

1. Shimizu W : The long QT syndrome: Therapeutic implications of a genetic diagnosis. Cardiovasc Res 2005 67 : 347 356.
2. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA : Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006 114 : 2104 2112.
3. Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B, Valdivia C, Ueda K, Canizales-Quinteros S, Tusié-Luna MT, Makielski JC, Ackerman MJ : SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007 116 : 134 142.
4. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995 92 : 3381 3386.
5. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R : Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001 103 : 89 95.
6. Schwartz PJ, Zara A, Locati E, Moss AJ : Stress and sudden death. The case of long QT syndrome. Circulation 1991 83 (Suppl II II70 II80.
7. Wilde AA, Jongbloed RJ, Doevendans PA, Düren DR, Hauer RN, van Langen IM, van Tintelen JP, Smeets HJ, Meyer H, Geelen JL : Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 1999 33 : 327 332.
8. Bazett HC : An analysis of the time-relations of electrocardiograms. Heart 1920 7 : 353 370.
9. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS : Diagnostic criteria for the long QT syndrome: An update. Circulation 1993 88 : 782 784.
10. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin JA, Priori SG, Kamakura S : Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: Multicenter study in Japan. J Am Coll Cardiol 2004 44 : 117 125.
11. Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S : Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007 115 : 2481 2489.
12. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z : Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002 105 : 794 799.
13. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT : Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics 1998 51 : 86 97.
14. Wang Q, Li Z, Shen J, Keating MT : Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996 34 : 9 16.
15. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ : Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med 1998 339 : 960 965.
16. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D : Risk stratification in the long-QT syndrome. N Engl J Med 2003 348 : 1866 1874.
17. Lopez-Barneo J, Hoshi T, Heinemann SH, Aldrich RW : Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels 1993 1 : 61 71.
18. Choy AM, Lang CC, Chomsky DM, Rayos GH, Wilson JR, Roden DM : Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation 1997 96 : 2149 2154.
19. + channels. Circ Res 1998 82 : 739 750.
20. Tan HL, Bardai A, Shimizu W, Moss AJ, Schulze-Bahr E, Noda T, Wilde AAM : Genotype-specific onset of arrhythmias in congenital long-QT syndrome: Possible therapy implications. Circulation 2006 114 : 2096 2103.
21. (Ks) does not induce early afterdepolarization activity but promotes beta-adrenergic agonist-induced delayed afterdepolarization activity. J Cardiovasc Electrophysiol 2000 11 : 458 465.
22. Liu J, Laurita KR : The mechanism of pause-induced torsade de pointes in long QT syndrome. J Cardiovasc Electrophysiol 2005 16 : 981 987.
23. Ks) in canine ventricular myocytes. J Physiol 2003 551 : 777 786.
24. Tan HL, Hou CJ, Lauer MR, Sung RJ : Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995 122 : 701.
25. Kr potassium channel. Cell 1995 81 : 299 307.
26. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC : A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A 2000 97 : 12329 12333.
27. Priori SG, Napolitano C, Schwartz PJ : Low penetrance in the long-QT syndrome clinical impact. Circulation 1999 99 : 529 533.